Advertisement

Bladder Preservation Approaches

Chapter

Abstract

As more and more patients are living longer, they bring with them a host of chronic conditions. Often times, these comorbidities may prevent patients from being optimal candidates for the standard treatment for invasive or high-grade bladder cancer. This chapter briefly looks at some therapeutic surgical options for patients who are not ideal candidates for a prolonged radical cystectomy with concomitant reconstruction of the urinary tract.

Keywords

Bladder cancer Partial cystectomy Bladder preservation Robotic surgery Radical TURBT Chemotherapy for bladder cancer 

References

  1. 1.
    Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, et al. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech. 2012;22(1):17–21.CrossRefGoogle Scholar
  2. 2.
    Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin N Am. 2005;32(2):187–97.CrossRefGoogle Scholar
  3. 3.
    Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol Eur Assoc Urol. 2012;6:1–13.Google Scholar
  4. 4.
    Raboy A, Adler H, Albert P. Extraperitoneal endoscopic pelvic lymph node dissection: a review of 125 patients. J Urol. 1997;158(6):2202–4.Google Scholar
  5. 5.
    Chamie K, Hu B, deVere White RW, Ellison LM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int. 2008;102(3):284–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Liu JJ, Droller MJ, Liao JC. New optical imaging technologies for bladder cancer: considerations and perspectives. J Urol. 2012;188(2):36–8. Elsevier Inc.CrossRefGoogle Scholar
  7. 7.
    Ray ER, Chatterton K, Khan MS, Chandra A, Thomas K, Dasgupta P, O’Brien TS. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin. BJU Int. 2010;105(6):789–94.CrossRefPubMedGoogle Scholar
  8. 8.
    Olsona E, Iborra I, Ricos JV, Monros JL, Casanova J, Calabuig C. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term follow-up of a prospective study. J Urol. 1998;159:95–8.CrossRefGoogle Scholar
  9. 9.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J Urol. 2006;175(6):2058–62.CrossRefPubMedGoogle Scholar
  10. 10.
    Allaparthi S, Ramanathan R, Balaji KC. Robotic partial cystectomy for bladder cancer: a single-institutional pilot study. J Endourol. 2010;24(2):223–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Khosravi-Shahi P, Cabezón-Gutiérrez L. Selective organ preservation in muscle-invasive bladder cancer: review of the literature. Surg Oncol. 2012;21(1):e17–22. Elsevier Ltd.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2015

Authors and Affiliations

  1. 1.Department of UrologyTulane University School of MedicineNew OrleansUSA

Personalised recommendations